15-48437763-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000138.5(FBN1):c.6313+5G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000138.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Marfan syndrome Uncertain:1
This is a de novo variant in this patient (parental studies for this variant performed). RNA studies previously performed on DNA from this patient - classified as a VUS variant: The RNA studies findings confirm that this variant effect aberrant splicing, however quantitative estimates indicates the aberrant transcript (FBN1:r.6313_6314ins57) is present at the limit of detection of the assay (~10%) (ie. wildtype FBN1:r.= : aberrant FBN1:r.6313_6314ins57 transcript ratio of appx 90:10 from the total mRNA. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.